BioCentury | Jun 16, 2014
Company News

Abzena, Alpha Cancer deal

...not be reached for details. In February, Alpha Cancer signed a letter of intent with Bradmer Pharmaceuticals Inc....
BioCentury | Feb 24, 2014
Company News

Alpha Cancer, Bradmer deal

...held, and Bradmer shareholders will receive one common share of the newco for every 7.91 Bradmer...
...merger and assuming C$10 million is raised in the private placement, the companies expect existing Bradmer...
...Phase I testing for ovarian cancer in 3Q14. Alpha Cancer Technologies Inc. , Toronto, Ontario Bradmer Pharmaceuticals Inc....
BioCentury | Jun 18, 2012
Company News

Bradmer, Epic Production Technologies International Inc. deal

...The companies mutually terminated a letter of intent to combine businesses through a reverse merger. Bradmer...
...lighting, rigging, audio, video and project management to sports and entertainment venues. In May 2009, Bradmer...
...headcount to about three to conserve cash as it evaluated strategic alternatives. In February 2009, Bradmer...
BioCentury | Jan 2, 2012
Company News

Bradmer, Epic Production Technologies International Inc. deal

...lighting, rigging, audio, video and project management to sports and entertainment venues. In May 2009, Bradmer...
...headcount to about three to conserve cash as it evaluated strategic alternatives. In February 2009, Bradmer...
...Phase III GLASS-ART trial of Neuradiab for newly diagnosed glioblastoma multiforme (GBM). In March 2011, Bradmer...
BioCentury | Aug 9, 2010
Financial News

Bradmer completes private placement

Bradmer Pharmaceuticals Inc. (TSX:BMR), Toronto, Ontario Business: Cancer Date completed: 7/29/10 Type: Private placement Raised: C$499,999 (US$488,849) Shares: 5.3 million Price: C$0.10 Shares after offering: 19.7 million WIR Staff cancer...
BioCentury | Apr 5, 2010
Financial News

Bradmer completes private placement

Bradmer Pharmaceuticals Inc. (TSX:BMR), Toronto, Ontario Business: Cancer Date completed: 3/26/10 Type: Private placement Raised: C$795,145 (US$778,447) Shares: 8.4 million Price: C$0.10 Shares after offering: 14.4 million Placement agent: Wildlaw Capital Markets Investors: Not disclosed...
BioCentury | Jul 9, 2009
Distillery Therapeutics

Indication: Autoimmune disease

...investigating how TNC activates downstream proinflammatory TLR4 signaling and determining how to inhibit that mechanism. Bradmer Pharmaceuticals Inc.'s...
BioCentury | Jul 6, 2009
Finance

Restructuring Watch

...lipase inhibitor to treat obesity, once it has secured a partner outside of Japan 5/20/09 Bradmer Pharmaceuticals Inc....
BioCentury | May 18, 2009
Company News

Bradmer cancer news

...to about three to conserve cash as it continues to evaluate strategic alternatives. In February, Bradmer...
...31, 2008, Bradmer had a 12-month operating loss of $11.8 million (see BioCentury, Feb. 23). Bradmer Pharmaceuticals Inc....
BioCentury | Feb 23, 2009
Finance

Ebb & Flow

...DNA alkylating agent. Vion was up $0.10 (26%) to $0.48 on the week. Clinical milestones Bradmer...
Items per page:
1 - 10 of 32
BioCentury | Jun 16, 2014
Company News

Abzena, Alpha Cancer deal

...not be reached for details. In February, Alpha Cancer signed a letter of intent with Bradmer Pharmaceuticals Inc....
BioCentury | Feb 24, 2014
Company News

Alpha Cancer, Bradmer deal

...held, and Bradmer shareholders will receive one common share of the newco for every 7.91 Bradmer...
...merger and assuming C$10 million is raised in the private placement, the companies expect existing Bradmer...
...Phase I testing for ovarian cancer in 3Q14. Alpha Cancer Technologies Inc. , Toronto, Ontario Bradmer Pharmaceuticals Inc....
BioCentury | Jun 18, 2012
Company News

Bradmer, Epic Production Technologies International Inc. deal

...The companies mutually terminated a letter of intent to combine businesses through a reverse merger. Bradmer...
...lighting, rigging, audio, video and project management to sports and entertainment venues. In May 2009, Bradmer...
...headcount to about three to conserve cash as it evaluated strategic alternatives. In February 2009, Bradmer...
BioCentury | Jan 2, 2012
Company News

Bradmer, Epic Production Technologies International Inc. deal

...lighting, rigging, audio, video and project management to sports and entertainment venues. In May 2009, Bradmer...
...headcount to about three to conserve cash as it evaluated strategic alternatives. In February 2009, Bradmer...
...Phase III GLASS-ART trial of Neuradiab for newly diagnosed glioblastoma multiforme (GBM). In March 2011, Bradmer...
BioCentury | Aug 9, 2010
Financial News

Bradmer completes private placement

Bradmer Pharmaceuticals Inc. (TSX:BMR), Toronto, Ontario Business: Cancer Date completed: 7/29/10 Type: Private placement Raised: C$499,999 (US$488,849) Shares: 5.3 million Price: C$0.10 Shares after offering: 19.7 million WIR Staff cancer...
BioCentury | Apr 5, 2010
Financial News

Bradmer completes private placement

Bradmer Pharmaceuticals Inc. (TSX:BMR), Toronto, Ontario Business: Cancer Date completed: 3/26/10 Type: Private placement Raised: C$795,145 (US$778,447) Shares: 8.4 million Price: C$0.10 Shares after offering: 14.4 million Placement agent: Wildlaw Capital Markets Investors: Not disclosed...
BioCentury | Jul 9, 2009
Distillery Therapeutics

Indication: Autoimmune disease

...investigating how TNC activates downstream proinflammatory TLR4 signaling and determining how to inhibit that mechanism. Bradmer Pharmaceuticals Inc.'s...
BioCentury | Jul 6, 2009
Finance

Restructuring Watch

...lipase inhibitor to treat obesity, once it has secured a partner outside of Japan 5/20/09 Bradmer Pharmaceuticals Inc....
BioCentury | May 18, 2009
Company News

Bradmer cancer news

...to about three to conserve cash as it continues to evaluate strategic alternatives. In February, Bradmer...
...31, 2008, Bradmer had a 12-month operating loss of $11.8 million (see BioCentury, Feb. 23). Bradmer Pharmaceuticals Inc....
BioCentury | Feb 23, 2009
Finance

Ebb & Flow

...DNA alkylating agent. Vion was up $0.10 (26%) to $0.48 on the week. Clinical milestones Bradmer...
Items per page:
1 - 10 of 32